Editas Medicine, Inc. (EDIT) financial statements (2021 and earlier)

Company profile

Business Address 11 HURLEY ST.
CAMBRIDGE, MA 02141
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments402457369329185
Cash and cash equivalents140238135147185
Short-term investments262219234183 
Restricted cash and investments422  
Receivables60010
Prepaid expense  322
Other undisclosed current assets75110
Total current assets:419464375332187
Noncurrent Assets
Operating lease, right-of-use asset2529
Property, plant and equipment1411403940
Long-term investments and receivables110    
Long-term investments110    
Other noncurrent assets55522
Total noncurrent assets:15445464142
TOTAL ASSETS:573509420373229
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3028181522
Accounts payable66545
Accrued liabilities2422131117
Deferred revenue2124
Debt 6   
Deferred revenue and credits13 
Contract with customer, liability16
Other liabilities 3211
Other undisclosed current liabilities7  810
Total current liabilities:5860363733
Noncurrent Liabilities
Long-term debt and lease obligation1923323335
Capital lease obligations323335
Operating lease, liability1923
Liabilities, other than long-term debt1011631169526
Deferred revenue and credits9526
Accounts payable and accrued liabilities    0
Deferred revenue74163
Contract with customer, liability116
Other liabilities280000
Total noncurrent liabilities:12118614812861
Total liabilities:17924618416595
Stockholders' equity
Stockholders' equity attributable to parent394262236208135
Common stock00000
Additional paid in capital1,059812652514320
Accumulated other comprehensive income (loss)(0)0(0)(0) 
Accumulated deficit(665)(549)(416)(306)(186)
Total stockholders' equity:394262236208135
TOTAL LIABILITIES AND EQUITY:573509420373229

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenue, net146
Gross profit:912132146
Operating expenses(226)(161)(146)(134)(103)
Operating loss:(135)(141)(114)(120)(97)
Nonoperating income (expense)1974(0)0
Investment income, nonoperating373(1)0
Other nonoperating income (expense)16(0)01(0)
Net loss attributable to parent:(116)(134)(110)(120)(97)
Preferred stock dividends and other adjustments    (0)
Net loss available to common stockholders, diluted:(116)(134)(110)(120)(97)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(116)(134)(110)(120)(97)
Other comprehensive income (loss)(0)00(0) 
Comprehensive loss, net of tax, attributable to parent:(116)(134)(110)(120)(97)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: